2nd Abu Dhabi Haematology Annual Review (ADHAR)

We are delighted to welcome you to the 2nd Abu Dhabi Haematology Annual Review (ADHAR), proudly hosted by the Haematology Department at Sheikh Shakhbout Medical City (SSMC). The conference will be held on 26–27 September, 2025 at the Dusit Thani Abu Dhabi Hotel, under the esteemed leadership of Dr. Koroush Lotfi and Dr. Kayane Mheidly.

This year’s program offers a dynamic and comprehensive agenda, highlighting the latest advances in haematological disorders, innovative treatments, and best practices from across the field. Over the course of two days, ADHAR will bring together leading experts, clinicians, and researchers to foster impactful learning, meaningful collaboration, and a shared commitment to elevating haematology care across the MENA region.

We look forward to welcoming you to Abu Dhabi and to SSMC’s continuing journey of excellence in haematology.

This year’s event brings together regional and international experts for two days of high-impact learning, networking, and clinical insight.

Day 1 will feature the CTCL MENA Working Group Annual Conference, offering focused sessions on Cutaneous T-cell Lymphoma and updates in the regional landscape.

Day 2 presents a diverse mix of scientific topics, designed to provide clinicians with practical knowledge and evidence-based updates across the haematology spectrum. Whether you are a practising haematologist, oncologist, or general physician, this meeting is curated to support your clinical practice and continuous professional development.

Coming Soon…

Dr. Reem El Bahtimi

Medical Director, International Dermpath Consult
Consultant Pathology, Anatomical Pathology and Dermatology
International Dermpath Consult, UAE

Dr. Jihan Helal

Consultant Dermatologist
As’ad Al-Hamad Dermatology Center, Kuwait

Dr. Rasha Abdeltawab

Consultant Haematologist/Haemato-Oncologist
Kuwait Cancer Control Center, Kuwait

Dr. Elfadel Alshibani

Consultant Haematologist
King Faisal Specialist Hospital and Research Center, KSA

Dr. Mohamed Rizwanullah

Consultant Radiation Oncologist
King Faisal Specialist Hospital and Research Center, KSA

Dr. Mona Abdel Halim

Consultant Dermatologist
Ain Al Shams University, Egypt

Dr. Dina Elkady

Consultant Haematologist/Hemato-Oncologist
South Egypt Cancer Institute, Kuwait

Ms. Linda Hariss

Charge Nurse
Sheikh Shakhbout Medical City, Abu Dhabi, UAE

Dr. Inas El-Najjar

Consultant Haematologist
Abu Dhabi Stem Cells Center (ADSCC), UAE

Dr. Shabeeha Rana

Consultant Haematologist/Hemato-Oncologist
Kings College Hospital London, UAE

Ms. Farah Farroukh

Charge Nurse
UAE

Dr. Ruba Taha

Senior Consultant Physician in Haematology
Hamad Medical Center, Qatar

Dr. Panagiotis Kalogiannidis

Consultant Haematologist
Burjeel Medical City, UAE

Dr. Mohamed Yassin

Consultant Haematologist
Hamad Medical Center, Qatar

Dr. Kourosh Lotfi

Consultant Haematologist
Sheikh Shakhbout Medical City, Abu Dhabi, UAE

Dr. Muna Adam

Clinical Haematology Specialist
Sheikh Shakhbout Medical City, Abu Dhabi, UAE

Dr. Khaled Musallam

Group Chief Research Officer (Burjeel Holdings)
Founding Director, Center for Research on Rare Blood Disorders (CR-RBD)
Director, Thalassemia and Sickle Cell Center
Head, Innovative Trials Unit, Genetics and Rare Disease Center
Burjeel Medical City, UAE

Dr. Emmanouil Nikolousis

Director of BMT and Cancer Centre
Consultant Haematologist
American Hospital Dubai, UAE

Dr. Ayman Alhejazi

Consultant Haematologist
King Abdulaziz Medical City, KSA

Dr. Hadi Skouri

Consultant Cardiologist
Sheikh Shakhbout Medical City, Abu Dhabi, UAE

Dr. Robert Swaka

Consultant Infectious Diseases
Sheikh Shakhbout Medical City, Abu Dhabi, UAE

Dr. Aydah Al Awadhi

Chair, Haematology & Oncology Division
Consultant, Medical Oncology
Sheikh Shakhbout Medical City, Abu Dhabi, UAE

Dr. Kourosh Lotfi

Co-Chair of the Conference
Consultant Haematologist
Sheikh Shakhbout Medical City, Abu Dhabi, UAE

Dr. Kayane Mheidly

Co-Chair of the Conference
Consultant Haematologist
Lebanon

Dr. Atlal Al Lafi

President, Kuwait Society of Dermatologist (KSD)
Chairman of Dermatology Council, Kuwait
Head of As’ad Al Hamad Dermatology Center
Consultant Dermatologist
Kuwait

Dr. Muna Almurrawi

Consultant Dermatologist
UAE

Dr. Khalil Al Farsi

Consultant Haematologist
Oman

Prof. Chalid Assaf

Director of the Department of Dermatology and Venerology
Consultant Dermatologist
Helios Hospital Krefeld, Germany

Dr. Amar Lal

Consultant Haematology and Oncology
Tawam Hospital, UAE

Dr. Nathalie Jaque

Consultant Haematologist
Clemenceau Medical Center Hospital, Dubai, UAE

Dr. Husni Al Hateeti

Consultant Haematologist
Sheikh Shakhbout Medical City, Abu Dhabi, UAE

Dr. Fadwa AbdelAzim

Professor at Cairo University School of Medicine
Consultant of Haematopathology – Clinical Hematology
University Hospital Sharjah, UAE

Coming soon…

Time Agenda Speaker
26 SEPTEMBER 2025 DAY 1
18:00 – 18:30 Registration
Primary Hall Moderators: Dr. Atlal (Kuwait), Dr. Almurrawi (UAE), Dr. Al Farsi (Oman), Prof. Assaf (Germany)
18:30 – 18:45 Spectrum of CD30 Lymphoproliferation

Dr. Reem El Bahtimi
International Dermpath Consult, UAE

18:45 – 19:00 Cutaneous lymphoma in children

Dr. Gihan Helal
As’ad AlHamad Dermatology Center, Kuwait

19:00 – 19:15 Overview in the treatment of CTCL

Dr. Rasha Abdeltawab
Kuwait Cancer Control Centre, Kuwait

19:15 – 19:30 Treatment of B-cell lymphoma

Dr. Alfadel Alshaibani
King Faisal Specialist Hospital, KSA

19:30 – 19:45 Role of radiotherapy in cutaneous lymphoma

Dr. Mohamed Rizwanullah
King Faisal Specialist Hospital, KSA

19:45 – 20:00 Tumor microenvironment in CTCL

Dr. Mona Abdel Halim
Ain Sham University, Egypt

20:00 – 20:15 Flow cytometry in CTCL

Dr. Dina Elkady
Kuwait Cancer Control Centre, Kuwait

20:15 Summary
20:30 -21:00 Nurse Navigators in Haematology: The CALGB Protocol Experience

Ms. Linda Harris
Sheikh Shakhbout Medical City, Abu Dhabi, UAE

Secondary Hall
20:30 -21:00 MENA – CTCL group assembly and elections
21:00 – 22:00 Dinner
27 SEPTEMBER 2025 DAY 2
08:30-09:00 Registration
Session Moderator: Dr. Kourosh Lotfi
09:00-09:30 Multiple Myeloma frontline management from induction to maintenance

Dr. Inas El-Najjar
ADSCC, UAE

09:30-10:00 Sequencing of R/R MM management

Dr. Shabeeha Rana
Kings College Hospital London, UAE

10:00-10:15 Break
10:15-10:20 Opening: Dr. Aydah Al Awadhi
Session Moderator: Dr. Amar Lal
10:20-10:50 Bispecific T-Cell Engagers in Haematology: Transforming Cancer Treatment and Nursing Care

Ms. Farah Farroukh
Sheikh Shakhbout Medical City, Abu Dhabi, UAE

Moderator: Dr. Hani Osman
10:50-11:10 Beyond the Horizon: Optimizing the management of FLT3+ R/R AML (Astellas Symposium)

Dr. Muna Adam
Sheikh Shakhbout Medical City, Abu Dhabi, UAE

11:10-11:40 Follicular Lymphoma: treatment paradigm and the place of bispecific in the relapse setting

Dr. Ruba Taha
HMC, Qatar

11:40-12:10 CART Cells: Implementation and Challenges: KSA experience

Dr. Ayman AlHejazi
King Abdulaziz Medical City, Riyadh

12:10-13:00 Lunch Break
Session Moderators: Dr. Nathalie Jaques & Dr. Kayane Mheidly
13:00-13:30 Therapy for patients with AML , not fit for intensive chemothepy

Dr. Panagiotis Kalogiannidis
Burjeel Medical City , UAE

13:30-13:50 Precision medicine in CML

Dr. Mahmoud Yassin (Virtual)
HMC, Qatar

13:50-14:10 STARGLO: A new curing hope for R/R DLBCL patient (Glofitamab GMOX) (ROCHE Symposium)

Dr. Nameer Al Saadawi
ADSCC, UAE

14:10- 14:40 Advanced Hodgkin Lymphoma Management

Dr. Kayane Mheidly
Hôtel-Dieu de France, Lebanon


Moderator: Dr. Husni Al Hateeti
14:40- 15:10 Taking the Leap in HL: New Opportunities with BrECADD (TAKEDA Symposium)

Dr. Nameer Al Saadawi
ADSCC, UAE

15:10-15:25 Break
15:25-15:45 ITP Panel: Clinical Cases & Best Treatment Strategy
Panel: Dr. Waed Jaber, SSMC, Dr. Mohamed Abu Haleeqa, ADSCC, Dr. Muna Adam, SSMC

Clinical cases Presented by: Dr. Muna Adam, SSMC, UAE
Moderator: Dr. Husni Al Hateeti
Moderator: Dr. Rehab Alblooshi

Session Moderators: Dr. Fadwa Said AbdelAzim, Dr. Kourosh Lotfi
15:45-16:15 Thalassemia Updates

Dr. Khaled Musallam
Burjeel Medical City, UAE

16:15-16:45 ALL: Bispecific in the Frontline: UAE Experience

Dr. Emmanouil Nikolousis
American Hospital Dubai, UAE

16:45-17:15 Long Term Follow up for Haematology Patients/Cancer Survivors

Dr. Hadi Skouri
Sheikh Shakhbout Medical City, Abu Dhabi, UAE

Dr. Robert Swaka
Sheikh Shakhbout Medical City, Abu Dhabi, UAE

17:15-17:45 Bridging Specialities: A Hematological Perspective on Iron Deficiency, Anemia, and the Role of IV Iron Therapy

Dr. Husni Al Hateeti
Sheikh Shakhbout Medical City, Abu Dhabi, UAE

17:45-18:00 Conference Closing Comments


Powered by Ajaxy